New study tracks Wegovy's safety in pregnancy
NCT ID NCT05872022
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows pregnant women who took Wegovy for obesity or overweight to see if it affects the baby's health. Researchers compare these women to similar pregnant women who did not take Wegovy. The goal is to check for birth defects and other health issues in infants during their first year of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novo Nordisk Investigational Site
Princeton, New Jersey, 08540, United States
-
Novo Nordisk Investigational Site
Madrid, Spain
-
Novo Nordisk Investigational Site
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Could a broader vitamin mix outperform standard prenatal supplements?
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Small cash rewards may keep HIV-positive mothers in treatment — a trial puts the idea to the test
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?